Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes

ABSTRACT Extracellular vesicles (EVs) are emerging as novel theranostic tools. Limitations related to clinical uses are leading to a new research area on design and manufacture of artificial EVs. Several strategies have been reported in order to produce artificial EVs, but there has not yet been a clear criterion by which to differentiate these novel biomaterials. In this paper, we suggest for the first time a systematic classification of the terms used to build up the artificial EV landscape, based on the preparation method. This could be useful to guide the derivation to clinical trial routes and to clarify the literature. According to our classification, we have reviewed the main strategies reported to date for their preparation, including key points such as: cargo loading, surface targeting strategies, purification steps, generation of membrane fragments for the construction of biomimetic materials, preparation of synthetic membranes inspired in EV composition and subsequent surface decoration.

[1]  Andreas Wagner,et al.  Liposome Technology for Industrial Purposes , 2010, Journal of drug delivery.

[2]  J. Aerts,et al.  Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma , 2013, Journal of extracellular vesicles.

[3]  A. Anel,et al.  Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells , 2015, Clinical and Translational Oncology.

[4]  A. Maldonado,et al.  Vesicular fractions of sunflower apoplastic fluids are associated with potential exosome marker proteins , 2009, FEBS letters.

[5]  Jaesung Park,et al.  Microfluidic filtration system to isolate extracellular vesicles from blood. , 2012, Lab on a chip.

[6]  Matt Trau,et al.  Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing , 2015, Scientific Reports.

[7]  M. Yáñez-Mó,et al.  Comparative analysis of EV isolation procedures for miRNAs detection in serum samples , 2016, Journal of extracellular vesicles.

[8]  M. Record,et al.  Proteomic Analysis of C2C12 Myoblast and Myotube Exosome-Like Vesicles: A New Paradigm for Myoblast-Myotube Cross Talk? , 2014, PloS one.

[9]  Andrew F. Hill,et al.  Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.

[10]  J. Le Pecq,et al.  Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.

[11]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[12]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[13]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[14]  S. Lim,et al.  Exosomes for drug delivery - a novel application for the mesenchymal stem cell. , 2013, Biotechnology advances.

[15]  L. Capretto,et al.  Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications. , 2013, Advanced drug delivery reviews.

[16]  Xiuli Zhao,et al.  A novel micro-emulsion and micelle assembling method to prepare DEC205 monoclonal antibody coupled cationic nanoliposomes for simulating exosomes to target dendritic cells. , 2015, International journal of pharmaceutics.

[17]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  G. Hermanson Chapter 3 – The Reactions of Bioconjugation , 2013 .

[19]  Christian Jungreuthmayer,et al.  Rapid liposome quality assessment using a lab-on-a-chip. , 2011, Lab on a chip.

[20]  Jaesung Park,et al.  Generation of nanovesicles with sliced cellular membrane fragments for exogenous material delivery. , 2015, Biomaterials.

[21]  J. Leonard,et al.  FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver , 2013, Pharmaceuticals.

[22]  Ronnie H. Fang,et al.  Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.

[23]  Joanne L Welton,et al.  Ready-made chromatography columns for extracellular vesicle isolation from plasma , 2015, Journal of extracellular vesicles.

[24]  Steven M Jay,et al.  Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. , 2015, Tissue engineering. Part B, Reviews.

[25]  J. Domen,et al.  Role of mesenchymal stem cell therapy in Crohn’s disease , 2012, Pediatric Research.

[26]  F. Aqil,et al.  Bovine milk-derived exosomes for drug delivery. , 2016, Cancer letters.

[27]  J. Tait,et al.  A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer , 2011, Journal of thrombosis and haemostasis : JTH.

[28]  Chris Gardiner,et al.  Measurement of refractive index by nanoparticle tracking analysis reveals heterogeneity in extracellular vesicles , 2014, Journal of extracellular vesicles.

[29]  Richard J Simpson,et al.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.

[30]  G. Gregoriadis Entrapment of drugs and other materials into liposomes , 2007 .

[31]  Myung Soo Kim,et al.  Using exosomes, naturally-equipped nanocarriers, for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[33]  B. Calabretta,et al.  Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects. , 2000, Journal of the National Cancer Institute.

[34]  A. Marcilla,et al.  Extracellular vesicles in food: Experimental evidence of their secretion in grape fruits , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  Myung Soo Kim,et al.  Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[36]  A. Anel,et al.  Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells. , 2013, Molecular pharmaceutics.

[37]  Yoon-Kyoung Cho,et al.  Emerging techniques in the isolation and characterization of extracellular vesicles and their roles in cancer diagnostics and prognostics. , 2016, The Analyst.

[38]  Manho Kim,et al.  Low pH increases the yield of exosome isolation. , 2015, Biochemical and biophysical research communications.

[39]  Jaesung Park,et al.  Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. , 2014, Lab on a chip.

[40]  Samuel A Wickline,et al.  Maximizing exosome colloidal stability following electroporation. , 2014, Analytical biochemistry.

[41]  D. Lasič,et al.  The mechanism of vesicle formation. , 1988, The Biochemical journal.

[42]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[43]  Ashish Kumar Agrawal,et al.  Exosomal formulation enhances therapeutic response of celastrol against lung cancer. , 2016, Experimental and molecular pathology.

[44]  Markus Antonietti,et al.  Vesicles and Liposomes: A Self‐Assembly Principle Beyond Lipids , 2003 .

[45]  Ji-Ho Park,et al.  Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration. , 2015, Nano letters.

[46]  G. Hermanson Zero-Length Crosslinkers , 2008 .

[47]  R. Schiffelers,et al.  Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.

[48]  P. Schlesinger,et al.  Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  C. Théry,et al.  Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.

[51]  D. Merlin,et al.  Plant derived edible nanoparticles as a new therapeutic approach against diseases , 2016, Tissue barriers.

[52]  M Kersaudy-Kerhoas,et al.  Exosome isolation: a microfluidic road-map. , 2015, Lab on a chip.

[53]  C. W. Nan,et al.  Corrigendum: Magnetization Reversal by Out-of-plane Voltage in BiFeO3-based Multiferroic Heterostructures , 2016, Scientific Reports.

[54]  Ali Khademhosseini,et al.  Organ-on-a-chip platforms for studying drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[55]  G. Weissmann,et al.  Interaction of alytic polypeptide, melittin, with lipid membrane systems. , 1969, The Journal of biological chemistry.

[56]  J. Weaver,et al.  Electroporation: A general phenomenon for manipulating cells and tissues , 1993, Journal of cellular biochemistry.

[57]  Jennifer A. Prescher,et al.  Copper-free click chemistry in living animals , 2010, Proceedings of the National Academy of Sciences.

[58]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[59]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[60]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[61]  David Pozo,et al.  Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[62]  M. Wood,et al.  Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[63]  Pieter Vader,et al.  Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[64]  Biao Lu,et al.  Development of exosome surface display technology in living human cells. , 2016, Biochemical and biophysical research communications.

[65]  P. Altevogt,et al.  Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation , 2012, PLoS biology.

[66]  J. Mcgrath,et al.  The response of multilamellar liposomes to freezing and thawing. , 1980, Cryobiology.

[67]  E. Moase,et al.  Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. , 2003, Cancer research.

[68]  A. Samad,et al.  Liposomal drug delivery systems: an update review. , 2007, Current drug delivery.

[69]  Yoshihiro Sasaki,et al.  Engineering hybrid exosomes by membrane fusion with liposomes , 2016, Scientific Reports.

[70]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[71]  F. Sánchez‐Madrid,et al.  Sorting it out: regulation of exosome loading. , 2014, Seminars in cancer biology.

[72]  Sébastien Roy,et al.  Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. , 2004, The Biochemical journal.

[73]  F. Rinaldi,et al.  Niosomes from 80s to present: the state of the art. , 2014, Advances in colloid and interface science.

[74]  Jian-Bing Fan,et al.  miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles , 2012, Molecular therapy. Nucleic acids.

[75]  G. Hermanson Chapter 4 – Zero-Length Crosslinkers , 2013 .

[76]  S. Raimondo,et al.  Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death , 2015 .

[77]  F. Szoka,et al.  Comparative properties and methods of preparation of lipid vesicles (liposomes). , 1980, Annual review of biophysics and bioengineering.

[78]  P. Paz,et al.  Exosome Display technology: applications to the development of new diagnostics and therapeutics. , 2005, Blood cells, molecules & diseases.

[79]  Sahil D. Shah,et al.  Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. , 2015, Methods.

[80]  Molly M Stevens,et al.  Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[81]  J. Le Pecq,et al.  Increasing vaccine potency through exosome antigen targeting. , 2011, Vaccine.

[82]  Robert Gurny,et al.  Current methods for attaching targeting ligands to liposomes and nanoparticles. , 2004, Journal of pharmaceutical sciences.

[83]  Martin Bencsik,et al.  Artificial exosomes as tools for basic and clinical immunology. , 2009, Journal of immunological methods.

[84]  Ji-Ho Park,et al.  Cellular Engineering with Membrane Fusogenic Liposomes to Produce Functionalized Extracellular Vesicles. , 2016, ACS applied materials & interfaces.

[85]  Michelle E. Hung,et al.  A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery , 2016, Journal of extracellular vesicles.

[86]  Jaesung Park,et al.  Large-scale generation of cell-derived nanovesicles. , 2014, Nanoscale.

[87]  S. Lim,et al.  Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. , 2013, Advanced drug delivery reviews.

[88]  M. Martínez-Lorenzo,et al.  Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[89]  G. Gutiérrez,et al.  Using Factorial Experimental Design To Prepare Size-Tuned Nanovesicles , 2016 .

[90]  P. Roingeard,et al.  Toxoplasma gondii Antigen-Pulsed-Dendritic Cell-Derived Exosomes Induce a Protective Immune Response against T. gondii Infection , 2004, Infection and Immunity.

[91]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[92]  Mansoor Amiji,et al.  Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. , 2015, Clinical immunology.

[93]  R. Nieuwland,et al.  Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.

[94]  Richard J. Simpson,et al.  ExoCarta as a resource for exosomal research , 2012, Journal of extracellular vesicles.

[95]  E. Lechman,et al.  Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[96]  Thomas J. Anchordoquy,et al.  Surface Functionalization of Exosomes Using Click Chemistry , 2014, Bioconjugate chemistry.

[97]  Jun Lu,et al.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. , 2013, The Journal of allergy and clinical immunology.

[98]  Saeid Moghassemi,et al.  Nano-niosomes as nanoscale drug delivery systems: an illustrated review. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[99]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[100]  Spain,et al.  Nanovesicles Are Secreted during Pollen Germination and Pollen Tube Growth : A Possible Role in Fertilization , 2014 .

[101]  N. Ishiguro,et al.  Comparison of methods for isolating exosomes from bovine milk. , 2012, The Journal of veterinary medical science.

[102]  Maria Carmen Blanco-López,et al.  Fully Artificial Exosomes: Towards New Theranostic Biomaterials. , 2018, Trends in biotechnology.

[103]  Richard J Simpson,et al.  A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. , 2015, Methods in molecular biology.

[104]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[105]  M. Wood,et al.  Exosomes for targeted siRNA delivery across biological barriers. , 2013, Advanced drug delivery reviews.

[106]  K. Braeckmans,et al.  Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[107]  Mario Gimona,et al.  Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use , 2017, International journal of molecular sciences.

[108]  P. Robbins,et al.  Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. , 2009, Arthritis and rheumatism.

[109]  Jan Lötvall,et al.  EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research. , 2015, Seminars in cell & developmental biology.

[110]  A. Seifalian,et al.  Exosomes as nano-theranostic delivery platforms for gene therapy. , 2013, Advanced drug delivery reviews.

[111]  M. R. Mozafari,et al.  Liposomes: an overview of manufacturing techniques. , 2005, Cellular & molecular biology letters.

[112]  Jaesung Park,et al.  Nanovesicles engineered from ES cells for enhanced cell proliferation. , 2014, Biomaterials.

[113]  Kwang Ryeol Lee,et al.  Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module , 2016, Nature Communications.

[114]  Leaf Huang,et al.  Immunoliposomes: Preparation, properties, and applications , 1986, Medicinal research reviews.